Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 1,730.20
-1.80 (-0.10%)
Jun 27, 2025, 10:30 AM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 488.77 billion as of June 26, 2025. Its market cap has increased by 43.16% in one year.
Market Cap
488.77B
Enterprise Value
496.44B
Revenue
134.35B
Ranking
n/a
PE Ratio
46.68
Stock Price
1,730.20
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 488.77B, an increase of 42,427.66%. That is a compound annual growth rate of 28.60%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,988.89B |
| Divi's Laboratories | 1,761.65B |
| Cipla | 1,210.83B |
| Apollo Hospitals Enterprise | 1,007.57B |
| Zydus Lifesciences | 958.04B |
| Mankind Pharma | 949.52B |
| Aurobindo Pharma | 638.71B |
| Fortis Healthcare | 569.73B |